Cannabinoid Hyperemesis Syndrome: A Review of the Presentation and Treatment

Pizarro-Osilla, 2018, What is cannabinoid hyperemesis syndrome?, J Emerg Nurs, 44, 665, 10.1016/j.jen.2018.07.014 Navon, 2020, Notes from the field: characteristics of tetrahydrocannabinol–containing e-cigarette, or vaping, products used by adults — Illinois, September–October 2019, MMWR Morb Mortal Wkly Rep, 69, 973, 10.15585/mmwr.mm6929a5 Brauns, 2020, From illegal to essential: as marijuana sales continue to break records, a local cannabis startup cashes in big with online sales, The Source Wkly United Nations Office on Drugs and Crime, World drug report 2019, Accessed February 1, 2019. https://www.unode.org/wdr2019 Orens A, Light M, Lewandowski B, Rowberry J, Saloga C. Market size and demand for marijuana in Colorado: 2017 market update. Accessed August 31, 2018. https://www.colorado.gov/pacific/sites/default/files/MED%20Demand%20and%20Market%20%20Study%20%20082018.pdf Cerdá, 2020, Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016, JAMA Psychiatry, 77, 165, 10.1001/jamapsychiatry.2019.3254 National Conference of State Legislatures. Marijuana overview. Published October 17, 2019. Accessed February 1, 2019. www.ncsl.org/research/civil-and-criminal-justice/marijuana-overview.aspx Monte, 2019, Acute illness associated with cannabis use, by route of exposure: an observational study, Ann Intern Med, 170, 531 Allen, 2004, Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse, Gut, 53, 1566, 10.1136/gut.2003.036350 Lapoint, 2018, Cannabinoid hyperemesis syndrome: public health implications and a novel model treatment guideline, West J Emerg Med, 19, 380, 10.5811/westjem.2017.11.36368 Sorensen, 2017, Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment-a systematic review, J Med Toxicol, 13, 71, 10.1007/s13181-016-0595-z Gharibans, 2018, Gastric slow wave spatial abnormalities are present and associated with cannabinoid hyperemesis syndrome among daily cannabis users: 473, Am J Gastroenterol, 113, S273, 10.14309/00000434-201810001-00473 Kim, 2015, Cyclic vomiting presentations following marijuana liberalization in Colorado, Acad Emerg Med, 22, 694, 10.1111/acem.12655 Deceuninck, 2019, Cannabinoid hyperemesis syndrome: a review of the literature, Psychiatr Danub, 31, 390 Galli, 2011, Cannabinoid hyperemesis syndrome, Curr Drug Abuse Rev, 4, 241, 10.2174/1874473711104040241 Soriano-Co, 2010, The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States, Dig Dis Sci, 55, 3113, 10.1007/s10620-010-1131-7 Kraemer, 2013, Some like it hot: erythema ab igne due to cannabinoid hyperemesis, J Gen Intern Med, 28, 1504, 10.1007/s11606-013-2446-9 Hernández-Ramos, 2019, Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome. Article in Spanish, An Sist Sanit Navar, 42, 227, 10.23938/ASSN.0635 Richards, 2017, Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review, Pharmacotherapy, 37, 725, 10.1002/phar.1931 Hickey, 2013, Haloperidol for treatment of cannabinoid hyperemesis syndrome, Am J Emerg Med, 31, 1003.e5, 10.1016/j.ajem.2013.02.021 Witsil, 2017, Haloperidol, a novel treatment for cannabinoid hyperemesis syndrome, Am J Ther, 24, e64, 10.1097/MJT.0000000000000157 Lee, 2019, The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome, Clin Toxicol (Phila), 57, 773, 10.1080/15563650.2018.1564324 Bloomfield, 2016, The effects of Δ9-tetrahydrocannabinol on the dopamine system, Nature, 539, 369, 10.1038/nature20153 Richards, 2018, Cannabinoid hyperemesis syndrome: pathophysiology and treatment in the emergency department, J Emerg Med, 54, 354, 10.1016/j.jemermed.2017.12.010 Dezieck, 2017, Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series, Clin Toxicol (Phila), 55, 908, 10.1080/15563650.2017.1324166 Biary, 2014, Topical capsaicin cream used as a therapy for cannabinoid hyperemesis syndrome, Clin Toxicol, 52, 787 Wagner, 2020, Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department, Clin Toxicol (Phila), 58, 471, 10.1080/15563650.2019.1660783 Mégarbane, 2020, Topical capsaicin to treat cannabinoid hyperemesis syndrome: mind the dose, Clin Toxicol (Phila), 58, 855, 10.1080/15563650.2019.1694683 Madireddy, 2019, Burden of comorbidities in hospitalizations for cannabis use-associated intractable vomiting during post-legalization period, Cureus, 11